 Connection
Anna Bruckner to Middle Aged
This is a "connection" page, showing publications Anna Bruckner has written about Middle Aged.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.175 |
|
|
|
-
Bruckner AL, Murrell D, Lee LW, Sprecher E, Kiritsi D, Maher L, Löwe S, Donovan M, Kern JS. Reduction in Dressing Change Burden in Patients With Epidermolysis Bullosa-Impact of Oleogel-S10. J Dermatol. 2025 Sep; 52(9):1447-1451.
Score: 0.048
-
Bruckner AL, Losow M, Wisk J, Patel N, Reha A, Lagast H, Gault J, Gershkowitz J, Kopelan B, Hund M, Murrell DF. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2020 01 03; 15(1):1.
Score: 0.032
-
Bruckner AL, Fairclough DL, Feinstein JA, Lara-Corrales I, Lucky AW, Tolar J, Pope E. Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB). Br J Dermatol. 2018 05; 178(5):1128-1134.
Score: 0.029
-
Luo AJ, Arkin LM, Asch S, Benjamin L, Bruckner AL, Cossio ML, Diaz L, Lilly E, Mathes EF, Nelson CA, Pope E, Ramachandran S, Siegel DH, Teng JMC, Xu Y, Deng Y, Paller AS, Choate KA. Reliability of the Ichthyosis Scoring System in Individuals With Skin of Color. JAMA Dermatol. 2025 Aug 01; 161(8):849-854.
Score: 0.012
-
Murrell DF, Bodemer C, Bruckner AL, Cunningham T, Davis C, Fernández MF, Kiritsi D, Maher L, Sprecher E, Torres-Pradilla M, Kern JS. Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study. Br J Dermatol. 2025 05 19; 192(6):1007-1017.
Score: 0.012
-
Pathmarajah P, Eid E, Nazaroff J, So J, Mittal V, Harris N, Li S, Lucky AW, Gorell ES, Peoples KG, Pope E, Lara-Corrales I, Paller AS, Wiss K, Perman MJ, Eichenfield LF, Levy ML, Morel KD, García-Romero MT, McCuaig CC, Saber M, Marinkovich MP, Oro A, Bruckner AL, Tang JY. Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2025 04 28; 192(5):917-925.
Score: 0.012
-
Shayegan LH, Levin LE, Galligan ER, Lucky AW, Bruckner AL, Pope E, Lara-Corrales I, Wiss K, McCuaig CC, Garzon MC, Eichenfield LF, Hook KP, Browning JC, Schachner LA, Perman MJ, Castelo-Soccio L, Levy ML, Glick SA, Morel KD. Skin cleansing and topical product use in patients with epidermolysis bullosa: Results from a multicenter database. Pediatr Dermatol. 2020 Mar; 37(2):326-332.
Score: 0.008
-
Hashimoto T, Teye K, Hashimoto K, Wozniak K, Ueo D, Fujiwara S, Inafuku K, Kotobuki Y, Jukic IL, Marinovic B, Bruckner A, Tsuruta D, Kawakami T, Ishii N. Clinical and Immunological Study of 30 Cases With Both IgG and IgA Anti-Keratinocyte Cell Surface Autoantibodies Toward the Definition of Intercellular IgG/IgA Dermatosis. Front Immunol. 2018; 9:994.
Score: 0.007
-
Danial C, Adeduntan R, Gorell ES, Lucky AW, Paller AS, Bruckner AL, Pope E, Morel KD, Levy ML, Li S, Gilmore ES, Lane AT. Evaluation of Treatments for Pruritus in Epidermolysis Bullosa. Pediatr Dermatol. 2015 Sep-Oct; 32(5):628-34.
Score: 0.006
-
Fortuna G, Lozada-Nur F, Pollio A, Aria M, Cepeda-Valdes R, Marinkovich MP, Bruckner AL, Salas-Alanís JC. Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. J Oral Pathol Med. 2013 Nov; 42(10):733-40.
Score: 0.005
-
Fortuna G, Chainani-Wu N, Lozada-Nur F, Aria M, Cepeda-Valdes R, Pollio A, Marinkovich MP, Martinez-Salazar AE, Mignogna MD, Bruckner AL, Salas-Alanís JC. Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment. J Am Acad Dermatol. 2013 Jan; 68(1):83-92.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|